This pilot study aims to 1) determine the feasibility and effect size for 20 sessions of repetitive transcranial magnetic stimulation (rTMS) versus sham in adults with a DSM 5 methamphetamine use disorder (MUD) or a cocaine use disorder (CUD; and 2) evaluate the safety of rTMS compared to sham in participants with CUD/MUD at the end of treatment and at a 12-week follow-up.
Principal Investigator(s)
Kathleen T. Brady, M.D., Ph.D.
125 Doughty Street, Suite 140
Charleston, SC 29403
United States
Madhukar H. Trivedi, M.D.
5323 Harry Hines Boulevard
Dallas, TX 75390
United States